Related Experiment Video
Updated: Feb 6, 2026

Intranasal Administration of CNS Therapeutics to Awake Mice
Published on: April 8, 2013
Subcutaneous auto-administration of trastuzumab following therapeutic education: A case report
Marine Deppenweiler1, Marc Debled2, Jean-Luc Robquin1
11 Department of Pharmacy, Institut Bergonié, Bordeaux, France.
Abstract:
Trastuzumab is a monoclonal antibody used to treat human epidermal growth receptor 2 positive (HER2+) breast cancers either by itself or in combination with other chemotherapy medication. Marketing authorization was granted for a subcutaneous form of the antibody in 2014. In this case report, we discuss our experience with a patient who took part in a therapeutic education program on self-administration of trastuzumab. We demonstrate that these types of self-administered injections are not only possible but also are toxicity-free. Based on the tolerance data and our patient's experience, we propose that the current regulations be relaxed regarding the availability of trastuzumab subcutaneous form in order to develop a cheaper "city scheme," i.e. self-administered injections.
Related Concept Videos
Types of Records II: Educational and Administrative Records
Data Reporting and Recording
Therapeutic Index
Types of Reports I: Hands-off Report
Following are the key components and categories of hand-off reports:
Purpose and Process:
Types of Reports II: Incident or Occurrence Report
Purposes:
In the healthcare industry, reports play a crucial role in documenting incidents within an agency. The primary objective of these reports is to ensure patient safety, uphold the...
Therapeutic Communication
Verbal communication depends on language or a prescribed way of using words so that people can share information effectively. The critical aspects of verbal...

